These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9175612)
1. Inhibition of AMPA receptor-stimulated 57Co2+ influx by D- and L-2-amino-4-phosphonobutanoic acid (D- and L-AP4) and L-serine-O-phosphate (L-SOP) in cultured cerebellar granule cells. Toms NJ; Hawkins LM; Roberts PJ Neuropharmacology; 1997 Mar; 36(3):335-43. PubMed ID: 9175612 [TBL] [Abstract][Full Text] [Related]
2. The effects of (RS)-alpha-cyclopropyl-4-phosphonophenylglycine ((RS)-CPPG), a potent and selective metabotropic glutamate receptor antagonist. Toms NJ; Jane DE; Kemp MC; Bedingfield JS; Roberts PJ Br J Pharmacol; 1996 Nov; 119(5):851-4. PubMed ID: 8922731 [TBL] [Abstract][Full Text] [Related]
3. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons. Liljequist S; Cebers G; Kalda A Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices. Bushell TJ; Jane DE; Tse HW; Watkins JC; Garthwaite J; Collingridge GL Br J Pharmacol; 1996 Apr; 117(7):1457-62. PubMed ID: 8730739 [TBL] [Abstract][Full Text] [Related]
6. Development of calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured neocortical neurons visualized by cobalt staining. Jensen JB; Schousboe A; Pickering DS J Neurosci Res; 1998 Oct; 54(2):273-81. PubMed ID: 9788286 [TBL] [Abstract][Full Text] [Related]
7. Inherent desensitisation-preventing properties of a novel, subtype-selective AMPA receptor agonist, (S)-CPW 399, as a possible explanation for its excitotoxic action in cultured cerebellar granule cells. Sinclair C; Reavy H; Grieve A; Schousboe A; Morelli E; Novellino E; Campiani G; Griffiths R Neurochem Int; 2003 May; 42(6):499-510. PubMed ID: 12547649 [TBL] [Abstract][Full Text] [Related]
8. Symptomatic and neuroprotective effects following activation of nigral group III metabotropic glutamate receptors in rodent models of Parkinson's disease. Austin PJ; Betts MJ; Broadstock M; O'Neill MJ; Mitchell SN; Duty S Br J Pharmacol; 2010 Aug; 160(7):1741-53. PubMed ID: 20649576 [TBL] [Abstract][Full Text] [Related]
9. Membrane currents evoked by excitatory amino acid agonists in ON bipolar cells of the mudpuppy retina. Thoreson WB; Miller RF J Neurophysiol; 1993 Oct; 70(4):1326-38. PubMed ID: 7506752 [TBL] [Abstract][Full Text] [Related]
10. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord. Howson PA; Jane DE Br J Pharmacol; 2003 May; 139(1):147-55. PubMed ID: 12746233 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships for a series of phenylglycine derivatives acting at metabotropic glutamate receptors (mGluRs). Bedingfield JS; Kemp MC; Jane DE; Tse HW; Roberts PJ; Watkins JC Br J Pharmacol; 1995 Dec; 116(8):3323-9. PubMed ID: 8719814 [TBL] [Abstract][Full Text] [Related]
12. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466). Parsons CG; Gruner R; Rozental J Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977 [TBL] [Abstract][Full Text] [Related]
13. Anion transport blockers inhibit DL-2-amino-4-phosphonobutyrate responses induced by quisqualate in the rat cerebral cortex. Turner JP Br J Pharmacol; 1993 Jun; 109(2):449-58. PubMed ID: 7689393 [TBL] [Abstract][Full Text] [Related]
14. Potentiation by DL-alpha-aminopimelate of the inhibitory action of a novel mGluR agonist (L-F2CCG-I) on monosynaptic excitation in the rat spinal cord. Saitoh T; Ishida M; Shinozaki H Br J Pharmacol; 1998 Feb; 123(4):771-9. PubMed ID: 9517398 [TBL] [Abstract][Full Text] [Related]
15. Potent antagonists at the L-AP4- and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord. Jane DE; Thomas NK; Tse HW; Watkins JC Neuropharmacology; 1996; 35(8):1029-35. PubMed ID: 9121605 [TBL] [Abstract][Full Text] [Related]
16. Modulation of non-N-methyl-D-aspartate receptors in cultured cerebellar granule cells. Gallo V; Giovannini C; Levi G J Neurochem; 1990 May; 54(5):1619-25. PubMed ID: 1969937 [TBL] [Abstract][Full Text] [Related]
17. Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse. Pisani A; Calabresi P; Centonze D; Bernardi G Neuropharmacology; 1997 Jun; 36(6):845-51. PubMed ID: 9225312 [TBL] [Abstract][Full Text] [Related]
18. Group II mGlu receptor agonists fail to protect against various neurotoxic insults induced in murine cortical, striatal and cerebellar granular pure neuronal cultures. Moldrich RX; Giardina SF; Beart PM Neuropharmacology; 2001 Jul; 41(1):19-31. PubMed ID: 11445182 [TBL] [Abstract][Full Text] [Related]
19. Properties of AMPA receptors expressed in rat cerebellar granule cell cultures: Ca2+ influx studies. Hack N; Balázs R J Neurochem; 1995 Sep; 65(3):1077-84. PubMed ID: 7543928 [TBL] [Abstract][Full Text] [Related]
20. Coupling of metabotropic glutamate receptors to phosphoinositide mobilisation and inhibition of cyclic AMP generation in the guinea-pig cerebellum. Neil KE; Kendall DA; Alexander SP Br J Pharmacol; 1996 May; 118(2):311-6. PubMed ID: 8735632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]